NO964416D0 - Fremgangsmåter for å fremstille effektive rekombinante serin protease inhibitorer og anvendelser av disse inhibitorene - Google Patents

Fremgangsmåter for å fremstille effektive rekombinante serin protease inhibitorer og anvendelser av disse inhibitorene

Info

Publication number
NO964416D0
NO964416D0 NO964416A NO964416A NO964416D0 NO 964416 D0 NO964416 D0 NO 964416D0 NO 964416 A NO964416 A NO 964416A NO 964416 A NO964416 A NO 964416A NO 964416 D0 NO964416 D0 NO 964416D0
Authority
NO
Norway
Prior art keywords
inhibitors
methods
serine protease
recombinant serine
preparing effective
Prior art date
Application number
NO964416A
Other languages
English (en)
Other versions
NO964416L (no
Inventor
Harvey Rubin
Barry Cooperman
Norman Schechter
Michael Plotnick
Zhi Mei Wang
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of NO964416L publication Critical patent/NO964416L/no
Publication of NO964416D0 publication Critical patent/NO964416D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO964416A 1994-04-18 1996-10-17 Fremgangsmåter for å fremstille effektive rekombinante serin protease inhibitorer og anvendelser av disse inhibitorene NO964416D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22928694A 1994-04-18 1994-04-18
US08/276,936 US5612194A (en) 1989-06-23 1994-07-19 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
PCT/US1995/004488 WO1995028422A1 (en) 1994-04-18 1995-04-11 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors

Publications (2)

Publication Number Publication Date
NO964416L NO964416L (no) 1996-10-17
NO964416D0 true NO964416D0 (no) 1996-10-17

Family

ID=26923159

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964416A NO964416D0 (no) 1994-04-18 1996-10-17 Fremgangsmåter for å fremstille effektive rekombinante serin protease inhibitorer og anvendelser av disse inhibitorene

Country Status (19)

Country Link
US (1) US5612194A (no)
EP (1) EP0765342A1 (no)
JP (1) JPH10501404A (no)
CN (1) CN1146207A (no)
AP (1) AP9600905A0 (no)
AU (1) AU2382195A (no)
BG (1) BG100981A (no)
BR (1) BR9507467A (no)
CA (1) CA2188180A1 (no)
CZ (1) CZ300396A3 (no)
FI (1) FI964174A (no)
HU (1) HUT75358A (no)
LV (1) LV11801A (no)
NO (1) NO964416D0 (no)
OA (1) OA10727A (no)
PL (1) PL316949A1 (no)
SI (1) SI9520043A (no)
SK (1) SK130696A3 (no)
WO (1) WO1995028422A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827662A (en) * 1989-06-23 1998-10-27 The Trustees Of The University Of Pennsylvania Methods for detecting genetic mutations resulting in protease inhibitor insufficiencies
US7171016B1 (en) 1993-11-18 2007-01-30 Digimarc Corporation Method for monitoring internet dissemination of image, video and/or audio files
DE19543750C2 (de) * 1995-11-24 1997-10-23 Crinos Industria Farmaco Cathepsin G inhibierende Aptamere
AU3866799A (en) * 1998-05-04 1999-11-23 Zymogenetics Inc. Cytoplasmic antiproteinase-3 coding sequence in gene therapy
US6849605B1 (en) 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
AU3731400A (en) 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
US6489308B1 (en) 1999-03-05 2002-12-03 Trustees Of University Of Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions
WO2002053172A2 (en) * 2000-12-29 2002-07-11 Kimberly-Clark Worldwide, Inc. Use of matrix metalloproteinase peptide substrate to lower the rate of extracellular matrix turnover
ES2431548T3 (es) * 2003-04-04 2013-11-26 Université de Lausanne Proteínas inhibidoras de una proteasa y su uso
USPP15990P3 (en) * 2003-04-23 2005-09-20 J. C. Bakker & Sons Limited Lilac plant named ‘Golden Eclipse’
PL2520654T3 (pl) 2003-08-26 2017-08-31 The Regents Of The University Of Colorado, A Body Corporate Inhibitory aktywności proteazy serynowej i ich zastosowanie w sposobach i kompozycjach do leczenia zakażeń bakteryjnych
KR101231126B1 (ko) * 2004-09-29 2013-02-07 가부시키가이샤 라이토 브락쿠 복2배체 수서동물과 그 육종법
AU2006297036A1 (en) * 2005-09-29 2007-04-05 University Of Alberta Compositions for and methods of granzyme B inhibition
CA2839917A1 (en) 2011-06-24 2012-12-27 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
KR20140137347A (ko) 2012-01-10 2014-12-02 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
JP2015111050A (ja) * 2012-03-28 2015-06-18 国立大学法人九州大学 Ｋａｌｌｉｓｔａｔｉｎ蛋白質による脳梗塞検査方法
CN103243105B (zh) * 2013-05-19 2018-11-02 中国农业科学院兰州兽医研究所 一种旋毛虫重组蛋白及应用
CN103275214A (zh) * 2013-06-08 2013-09-04 天津师范大学 对虾丝氨酸蛋白酶抑制剂的基因工程制备与鉴定方法
GB201322091D0 (en) 2013-12-13 2014-01-29 Cambridge Entpr Ltd Modified serpins for the treatment of bleeding disorders
CN104628845B (zh) * 2015-01-21 2017-12-08 中国人民解放军第二军医大学 一种发形霞水母丝氨酸蛋白酶抑制剂及其编码基因与应用
CN106478812B (zh) * 2016-10-21 2020-11-20 沈阳药科大学 丝氨酸蛋白酶抑制剂-3及其功能、制备方法和应用
CN110068676A (zh) * 2019-03-22 2019-07-30 同济大学 分泌蛋白Serpin A3在预测心肌损伤诊断试剂中的应用
CN110330564B (zh) * 2019-08-06 2022-09-20 上海景晗生物科技有限公司 丝氨酸蛋白酶抑制剂及其最小功能片段和免疫抑制作用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252725A (en) * 1989-06-23 1993-10-12 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production

Also Published As

Publication number Publication date
OA10727A (en) 2002-12-09
HU9602886D0 (en) 1996-12-30
AP9600905A0 (en) 1997-01-31
AU2382195A (en) 1995-11-10
CA2188180A1 (en) 1995-10-26
WO1995028422A1 (en) 1995-10-26
BG100981A (en) 1998-01-30
CN1146207A (zh) 1997-03-26
PL316949A1 (en) 1997-02-17
BR9507467A (pt) 1997-09-23
SI9520043A (en) 1997-08-31
SK130696A3 (en) 1997-07-09
FI964174A0 (fi) 1996-10-17
CZ300396A3 (en) 1997-08-13
FI964174A (fi) 1996-10-17
NO964416L (no) 1996-10-17
JPH10501404A (ja) 1998-02-10
LV11801A (lv) 1997-06-20
HUT75358A (en) 1997-05-28
US5612194A (en) 1997-03-18
EP0765342A1 (en) 1997-04-02

Similar Documents

Publication Publication Date Title
NO964416D0 (no) Fremgangsmåter for å fremstille effektive rekombinante serin protease inhibitorer og anvendelser av disse inhibitorene
AU2790895A (en) Purification of serine protease and synthetic inhibitors thereof
ZA916393B (en) Inhibitors of serine proteases
NO992734L (no) Serin-protease inhibitorer
NO983688D0 (no) Serin-protease-inhibitorer
NO990548D0 (no) Inhibitorer for cystein-protease
ATE264339T1 (de) Serine protease inhibitoren
DE69819349D1 (de) 1-amino-7-isochinolin-derivate als serin protease inhibitoren
PL333434A1 (en) Aminoguanidines and alkoxyguanidines as inhibitors of proteases
DK374286D0 (da) Serinproteaseinhibitorer og fremgangsmaade til isolering af disse
ATE277074T1 (de) Serine-protease-inhibitoren
ATE221080T1 (de) Serine-protease-inhibitoren
EP0923535A4 (en) CYSTEINE PROTEASE INHIBITORS
HK1016495A1 (en) Phosphorous-containing cysteine and serine protease inhibitors
AU7179598A (en) Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
CA2342985A1 (en) Hydroxamate-containing cysteine and serine protease inhibitors
GB2299583B (en) Peptidyl inhibitors of serine proteases
ZA915270B (en) Inhibitors of aspartic proteases
LT96158A (en) Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
GB9421426D0 (en) Peptide inhibitors of serine proteinases
NZ336908A (en) Substrates for human cytomegalovirus protease
GB9321696D0 (en) Peptide inhibitors of serine proteinases
GB9722405D0 (en) Peptide inhibitors of serine proteinases
EP1043987A4 (en) USE OF SERINE PROTEAS INHIBITORS FOR INHIBITING PATHOPHYSIOLOGY AND NEUROPATHOLOGY IN A HOST
GB9521813D0 (en) Peptide inhibitors of serine proteinases